HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 106 filers reported holding HERON THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.14 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $141 | +101.4% | 40,165 | -2.6% | 0.01% | +66.7% |
| Q4 2023 | $70 | +337.5% | 41,237 | +163.8% | 0.01% | +200.0% |
| Q3 2023 | $16 | -100.0% | 15,629 | -77.0% | 0.00% | -87.5% |
| Q2 2022 | $189,000 | -24.1% | 67,900 | +55.8% | 0.02% | -11.1% |
| Q1 2022 | $249,000 | +49.1% | 43,569 | +138.0% | 0.02% | +5.9% |
| Q4 2021 | $167,000 | -61.8% | 18,306 | -11.4% | 0.02% | -63.8% |
| Q4 2020 | $437,000 | -24.1% | 20,667 | -47.2% | 0.05% | -29.9% |
| Q2 2020 | $576,000 | +40.5% | 39,131 | +124.1% | 0.07% | +67.5% |
| Q4 2019 | $410,000 | -52.8% | 17,460 | -36.4% | 0.04% | -24.5% |
| Q3 2018 | $869,000 | +133.6% | 27,454 | +186.5% | 0.05% | +231.2% |
| Q2 2018 | $372,000 | +40.9% | 9,581 | +0.1% | 0.02% | +14.3% |
| Q1 2018 | $264,000 | -72.5% | 9,574 | -82.0% | 0.01% | -72.5% |
| Q4 2017 | $961,000 | +88.4% | 53,089 | +68.0% | 0.05% | +104.0% |
| Q3 2017 | $510,000 | – | 31,594 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN | 37,999 | $706,000 | 24.13% |
| TANG CAPITAL MANAGEMENT LLC | 5,744,096 | $106,783,000 | 14.43% |
| BRIDGER MANAGEMENT, LLC | 2,846,555 | $52,917,000 | 4.15% |
| First Light Asset Management, LLC | 1,098,723 | $20,425,000 | 2.84% |
| Broadfin Capital, LLC | 657,998 | $12,232,000 | 2.66% |
| HIGHLAND CAPITAL MANAGEMENT LP | 1,606,942 | $29,873,000 | 1.75% |
| EMORY UNIVERSITY | 129,020 | $2,398,000 | 1.69% |
| Mesirow Financial Investment Management, Inc. | 24,112 | $430,000 | 1.57% |
| Congress Park Capital LLC | 109,665 | $1,945,000 | 1.54% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 830,821 | $15,445,000 | 1.52% |